Changes to the Code
S. 4327 · Securing America’s Drug Supply from Communist China Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 381 Imports and exports
The bill's words for this section
- Not carried out:
Section 801 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381) is amended by adding at the end the following;(v) Import of drugs sponsored by PRC-, CCP-, and PLA-Affiliated entities.— (1) In general.— The Secretary shall furnish to the Commissioner of U.S. Customs and Border Protection a list of drugs for which the sponsor or holder of an approved application is determined under section 2(c) of the Securing America’s Drug Supply from Communist China Act to be a PRC-, CCP-, or PLA-affiliated entity. (2) Refusal.— If it appears that a drug imported or offered for import into the United States is a drug for which the sponsor or holder of an approved application is determined under section 2(c) of the Securing America’s Drug Supply from Communist China Act to be a PRC-, CCP-, or PLA-affiliated entity, then such drug shall be refused, except as provided in paragraphs (3) and (4), and the Commissioner of U.S. Customs and Border Protection shall destroy, without the opportunity for export, such drug. (3) Compliance.— (A) In general.— The Secretary shall establish a process under which the sponsor of a drug described in paragraph (2) or the holder of an approved application for such a drug, as applicable, may— (i) demonstrate to the Secretary that it is no longer a PRC-, CCP-, or PLA-affiliated entity; or (ii) within 180 days, sell the approved application for such drug to an entity that is not a PRC-, CCP-, or PLA-affiliated entity. (B) Requirement.— The process established under subparagraph (A) shall include the opportunity to appear before the Secretary and introduce testimony. (C) Notification.— If the Secretary is satisfied with the action taken under clause (i) or (ii) of subparagraph (A), the Secretary shall notify the Commissioner of U.S. Customs and Border Protection. (4) Waiver.— The Commissioner of U.S. Customs and Border Protection may waive the requirements of paragraph (2) and authorize the import of a drug described in such paragraph if the Secretary has determined that the refusal of the import would create or exacerbate a drug shortage in the United States. (5) Definition of PRC-, CCP-, or PLA-affiliated entity.— In this subsection, the term
PRC-, CCP-, or PLA-affiliated entity
has the meaning given such term in section 2(a) of the Securing America’s Drug Supply from Communist China Act..We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: adding at the end the following; QCONTENT.